Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1965 34
1966 64
1967 52
1968 57
1969 77
1970 78
1971 66
1972 79
1973 79
1974 75
1975 83
1976 101
1977 64
1978 107
1979 132
1980 86
1981 108
1982 129
1983 122
1984 119
1985 135
1986 129
1987 110
1988 127
1989 159
1990 133
1991 109
1992 131
1993 96
1994 131
1995 123
1996 118
1997 126
1998 118
1999 115
2000 129
2001 140
2002 150
2003 221
2004 227
2005 281
2006 324
2007 312
2008 370
2009 406
2010 460
2011 435
2012 497
2013 530
2014 599
2015 636
2016 675
2017 786
2018 837
2019 937
2020 1263
2021 1218
2022 1379
2023 1221
2024 527

Text availability

Article attribute

Article type

Publication date

Search Results

16,002 results

Results by year

Filters applied: . Clear all
Page 1
GRAPPA Treatment Recommendations: 2021 Update.
Coates LC, Corp N, van der Windt DA, O'Sullivan D, Soriano ER, Kavanaugh A. Coates LC, et al. J Rheumatol. 2022 Jun;49(6 Suppl 1):52-54. doi: 10.3899/jrheum.211331. Epub 2022 Mar 15. J Rheumatol. 2022. PMID: 35293339
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse).
Stein Gold LF, Bagel J, Tyring SK, Hong HC, Pavlovsky L, Vender R, Pinter A, Reich A, Drogaris L, Wu T, Patel M, Soliman AM, Photowala H, Stakias V, Richter S, Papp KA. Stein Gold LF, et al. Br J Dermatol. 2023 Oct 25;189(5):540-552. doi: 10.1093/bjd/ljad252. Br J Dermatol. 2023. PMID: 37488811 Clinical Trial.
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations.
Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H, De Jong E, Garcia-Doval I, Gisondi P, Kaur-Knudsen D, Mahil S, Mälkönen T, Maul JT, Mburu S, Mrowietz U, Reich K, Remenyik E, Rønholt KM, Sator PG, Schmitt-Egenolf M, Sikora M, Strömer K, Sundnes O, Trigos D, Van Der Kraaij G, Yawalkar N, Dressler C. Nast A, et al. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2461-2498. doi: 10.1111/jdv.16915. J Eur Acad Dermatol Venereol. 2020. PMID: 33349983
Targeted Therapy for Pediatric Psoriasis.
Nogueira M, Paller AS, Torres T. Nogueira M, et al. Paediatr Drugs. 2021 May;23(3):203-212. doi: 10.1007/s40272-021-00443-5. Epub 2021 Apr 3. Paediatr Drugs. 2021. PMID: 33811318 Review.
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.
Menter A, Gelfand JM, Connor C, Armstrong AW, Cordoro KM, Davis DMR, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Prater EF, Rahimi RS, Rupani RN, Siegel M, Stoff B, Strober BE, Tapper EB, Wong EB, Wu JJ, Hariharan V, Elmets CA. Menter A, et al. J Am Acad Dermatol. 2020 Jun;82(6):1445-1486. doi: 10.1016/j.jaad.2020.02.044. Epub 2020 Feb 28. J Am Acad Dermatol. 2020. PMID: 32119894
16,002 results
You have reached the last available page of results. Please see the User Guide for more information.